AKT1 and interstitial lung disease: PD + Cur inhibits the PI3K/AKT/TGF-β pathway by targeting and activating GABBR (Figure 6), which reduces the excessive immune-inflammatory response and fibrosis in the lung tissues of CTD-ILD.